Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Sierra Oncology, Inc. | d80749d10k.htm |
| EX-32.1 - EX-32.1 - Sierra Oncology, Inc. | d80749dex321.htm |
| EX-32.2 - EX-32.2 - Sierra Oncology, Inc. | d80749dex322.htm |
| EX-31.1 - EX-31.1 - Sierra Oncology, Inc. | d80749dex311.htm |
| EX-31.2 - EX-31.2 - Sierra Oncology, Inc. | d80749dex312.htm |
| EX-10.9 - EX-10.9 - Sierra Oncology, Inc. | d80749dex109.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-205693 on Form S-8 of our report dated March 3, 2016, relating to the consolidated financial statements of ProNAi Therapeutics, Inc. and subsidiaries (the “Company”) appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2015.
/s/ Deloitte & Touche LLP
Detroit, Michigan
March 3, 2016